What is the maximum duration of use for the TransPyloric Shuttle?

The TransPyloric Shuttle is a medical device designed for the treatment of obesity, specifically as a minimally invasive, adjustable gastric device that aims to promote weight loss by slowing gastric emptying and leading to earlier satiety. The recommended duration of use for the TransPyloric Shuttle is 12 months. This duration is based on clinical studies that have evaluated the safety and efficacy of the device over time.

After 12 months, the potential benefits of continuing use may diminish, and there can also be concerns with long-term implantation, such as device-related complications or changes in gastric physiology. Consequently, it is advised that after this period, patients be evaluated for the removal of the device to prevent any adverse effects and to assess the ongoing management of obesity.

The knowledge of this specific usage duration is crucial for practitioners when planning treatment for patients with obesity, ensuring that they align with the evidence-based practices surrounding the device.